Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Sumitomo presents new inhibitors of STAT6 activation

June 29, 1999

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

June 25, 1999

Avant achieves milestone in rotavirus vaccine program with SB

June 25, 1999

AM-6898E: new anti-IgE antibody agent for immune disorders

June 24, 1999

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

June 24, 1999

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Campylobacter vaccine completes phase II trial

June 17, 1999

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

June 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...